Tokyo, Japan

Hiroki Matsumoto


 


Average Co-Inventor Count = 9.5

ph-index = 3

Forward Citations = 21(Granted Patents)


Location History:

  • Sodegaura, JP (2015)
  • Tokyo, JP (2006 - 2018)

Company Filing History:


Years Active: 2006-2018

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Hiroki Matsumoto: Innovator in Radioactive Compounds

Introduction

Hiroki Matsumoto is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of radioactive compounds, holding a total of 6 patents. His work focuses on developing innovative compounds that have potential applications in medical and scientific research.

Latest Patents

Matsumoto's latest patents include a radioactive halogen-labeled pyrido[1,2-a]benzimidazole derivative compound. This invention relates to a compound represented by a specific general formula or a salt thereof, or a radiopharmaceutical comprising the same. Another notable patent is for a radioactive fluorine-labeled compound, which is represented by a specific formula where R denotes a hydrogen atom, a methyl group, or a hydroxymethyl group, and n is an integer of 1 or 2.

Career Highlights

Throughout his career, Matsumoto has worked with various companies, including Nihon Medi-Physics Company, Limited. His expertise in radioactive compounds has positioned him as a key figure in the industry, contributing to advancements in radiopharmaceuticals.

Collaborations

Matsumoto has collaborated with notable professionals in his field, including Eiji Yoshida and Keiichi Yahagi. These collaborations have further enhanced his research and development efforts in innovative compounds.

Conclusion

Hiroki Matsumoto's contributions to the field of radioactive compounds demonstrate his commitment to innovation and scientific advancement. His patents reflect a deep understanding of complex chemical structures and their potential applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…